← Back to headlines
AbbVie's $15 Billion Operational Beat Rewrites Bear Thesis
AbbVie's recent operational performance, exceeding expectations by $15 billion, has reportedly compelled a complete reevaluation of the bearish investment thesis surrounding the company's stock.
16 Jun, 20:42 — 16 Jun, 20:42
Sources
Showing 1 of 1 sources
